Application of a Network Scale-up Method to Estimate the Size of Population of Breast, Ovarian/Cervical, Prostate and Bladder Cancers

  • Haghdoost, Ali Akbar (Regional Knowledge Hub, and WHO Collaborating Centre for HIV Surveillance, Kerman University of Medical Sciences) ;
  • Baneshi, Mohammad Reza (Research Center for Modeling in Health, Kerman University of Medical Sciences) ;
  • Haji-Maghsoodi, Saeedeh (Research Center for Social Determinants of Health, Kerman University of Medical Sciences) ;
  • Molavi-Vardanjani, Hossein (Research Center for Health Services Management, Institute for Futures Studies in Health, Kerman University of Medical Sciences) ;
  • Mohebbi, Elham (Research Center for Modeling in Health, Kerman University of Medical Sciences)
  • Published : 2015.04.29


Network scale up (NSU) is a novel approach to estimate parameters in hard to reach populations through asking people the number of individuals they know in their active social network. Although the method have been used in hidden populations, advantages of NSU indicate that exploration of applicability to disease like cancer might be feasible. The aim of this study was to assess the application of NSU to estimate the size of the population of breast, ovarian/cervical, prostate, and bladder cancers in the South-east of Iran. A total of 3,052 (99% response rate) Kermanian people were interviewed in 2012-2013. Based on NSU, participants were asked about if they know any people on their social network who suffered from breast, ovarian/cervical, prostate, and bladder cancers, if yes, they should enumerate them. A total of 1,650 persons living with four types of cancers (breast, ovary/cervix, prostate, and bladder) were identified by the respondents. Totally, the prevalence of people living with the four types of cancers was 228.4 per 100,000 Kermanian inhabitants. The most prevalent cancer was breast cancer, at 168.9 per 100,000, followed by prostate cancer with 116.9, ovarian/cervical cancer with 99.8, and bladder cancer with 36.3 per 100000 Kerman city population. NSU values provide a usable but not very precise way of estimating the size of subpopulations in the context of the four major cancers (breast, ovary/cervix, prostate, and bladder).


Supported by : Kerman University of Medical Sciences


  1. Abbasalizadeh S, Abbasalizadeh F, Sahaf F, et al (2002). Assessment of the prevalence of breast cancer in the Northwest of Tabriz. Iran J Obstet Gynecol Infertility, 5, 54-7.
  2. Arab M, Khayamzadeh M, Mohit M, et al (2009). Survival of ovarian cancer in Iran: 2000-2004. Asian Pac J Cancer Prev, 10, 555-8.
  3. Arab M, Khayamzadeh M, Tehranian A, et al (2010). Incidence rate of ovarian cancer in Iran in comparison with developed countries. Indian J Cancer, 47, 322-7.
  4. Asadi K, Owji M, Vahdat S, et al (1999). Breast cancer among 30-65 women in Boushehr. Teb-e-Jonoub, 1, 217-22.
  5. Bernard HR, Hallett T, Iovita A, et al (2010). Counting hard-tocount populations: the network scale-up method for public health. Sex Transm Infect, 86, 11-5.
  6. Ezoe S, Morooka T, Noda T, et al (2012). Population size estimation of men who have sex with men through the network scale-up method in Japan. Plos one, 7, 31184.
  7. Fallah M (2007). Cancer incidence in five provinces of iran:ardebil, gilan, mazandaran, golestan and kerman, 1996-2000.
  8. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1. 0. Cancer incidence and mortality worldwide:IARC CancerBase.
  9. Fouladi N, Amani F, Harghi AS, et al (2011). Five year survival of women with breast cancer in Ardabil, north-west of Iran. Asian Pac J Cancer Prev, 12, 1799-801.
  10. Guo W, Bao S, Lin W, et al (2013). Estimating the size of HIV key affected populations in Chongqing, China, using the network scale-up method. PloS one, 8, 71796.
  11. Haghdoost AA, Baneshi MR, Eybpoosh S, et al (2013). Comparison of three interview methods on response pattern to sensitive and non-sensitive questions. Iran Red Crescent Med J, 15, 500.
  12. Heydari S, Mehrabani D, Tabei S, et al (2012). Survival of breast cancer in southern Iran. Iran J Cancer Prev, 2, 51-4.
  13. Jackson D, Kirkland J, Jackson B, et al (2005). Social network analysis and estimating the size of hard-to-count subpopulations1. Connect, 26, 49-60.
  14. Kadushin C, Killworth PD, Bernard HR, et al (2006). Scaleup methods as applied to estimates of heroin use. J Drug Issues, 36, 417-40.
  15. Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, et al (2015). Epidemiology and trend of cancers in the province of kerman: Southe Iran. Asian Pac J Cancer Prev, 16, 1409-13.
  16. McCarty C, Killworth PD, Bernard HR, et al (2001). Comparing two methods for estimating network size. Human Organizat, 60, 28-39.
  17. Mohebbi E, Baneshi MR, Haji-maghsoodi S, et al (2014). The application of network scale up method on estimating the prevalence of some disabilities in the Southeast of Iran. J Res Health Sci, 14, 272-5.
  18. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  19. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91.
  20. Parkin DM, Pisani P, Ferlay J (1999). Global cancer statistics. CA: Cancer J Clin, 49, 33-64.
  21. Rastegari A, Haji-Maghsoudi S, Haghdoost A, et al (2013). The estimation of active social network size of the Iranian population. Global J Health Sci, 5, 217.
  22. Rezaianzadeh A, Mohammadbeigi A, Mobaleghi J, et al (2012). Survival analysis of patients with bladder cancer, life table approach. J Mid-Life Health, 3, 88.
  23. Rezaianzadeh A, Peacock J, Reidpath D, et al (2009). Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC cancer, 9, 168.
  24. Russell Bernard H, Johnsen EC, Killworth PD, et al (1991). Estimating the size of an average personal network and of an event subpopulation: Some empirical results. Social Science Res, 20, 109-21.
  25. Sadjadi A, Nooraie M, Ghorbani A, et al (2007). The incidence of prostate cancer in Iran: results of a population-based cancer registry. Arch Iran Med, 10, 481-5.
  26. Sadjadi A, Semnani S, Nouraie SM, et al (2008). Cancer registry in Iran: a brief overview. Arch Iran Med, 11, 577.
  27. Salehi A, Khezri AA, Malekmakan L, Aminsharifi A. (2011). Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev, 12, 1323-7.
  28. Shamsnia SJ, Khezri AA, Tabbatabaei HR, et al (2013). Survival from Bladder Cancer in Shiraz, Southern Iran: A Hospital-Based Study. Middle-East J Sci Res, 18, 425-31.
  29. Sharifian A, Pourhoseingholi MA, Norouzinia M, et al (2014). Ovarian cancer in Iranian women, a trend analysis of mortality and incidence. Asian Pac J Cancer Prev, 15, 10787.
  30. Shokoohi M, Baneshi MR, Haghdoost AA (2010). Estimation of the active network size of kermanian males. Addict Health, 2.
  31. Snidero S, Morra B, Corradetti R, et al (2007). Use of the scaleup methods in injury prevention research: An empirical assessment to the case of choking in children. Social Networks, 29, 527-38.
  32. Talei AR, Sadeghi-Hassanabadi A, Salabian JA (1997). A preliminary report on breast cancer screening program in Shiraz Southern Iran. Iran J Med Sci, 22, 148.
  33. Vahdaninia M, Montazeri A (2004). Breast cancer in Iran: a survival analysis. Asian Pac J Cancer Prev, 5, 223-5.
  34. Veisy A, Lotfinejad S, Salehi K, et al (2015). Risk of breast cancer in relation to reproductive factors in North-west of Iran, 2013-2014. Asian Pac J Cancer Prev, 16, 451.
  35. Zahir ST, Nazemian MR, Zand S, et al (2014). Survival of patients with prostate cancer in Yazd, Iran. Asian Pac J Cancer Prev, 15, 883-6.

Cited by

  1. Total and Partial Prevalence of Cancer Across Kerman Province, Iran, in 2014, Using an Adapted Generalized Network Scale-Up Method vol.16, pp.13, 2015,
  2. Evaluation of Common Risk Factors for Breast Carcinoma in Females: a Hospital Based Study in Karachi, Pakistan vol.16, pp.15, 2015,